List of Veeva Vault QMS Customers
Pleasanton, 94588, CA,
United States
Since 2010, our global team of researchers has been studying Veeva Vault QMS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Veeva Vault QMS for Quality Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Veeva Vault QMS for Quality Management include: AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Samsung Biologics Co, a South Korea based Life Sciences organisation with 4400 employees and revenues of $1.20 billion, Recipharm, a Sweden based Life Sciences organisation with 9000 employees and revenues of $1.06 billion, Quotient Sciences, a United Kingdom based Life Sciences organisation with 1300 employees and revenues of $300.0 million, Unilever Mexico, a Mexico based Consumer Packaged Goods organisation with 3000 employees and revenues of $300.0 million and many others.
Contact us if you need a completed and verified list of companies using Veeva Vault QMS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Veeva Vault QMS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | Veeva Systems | Veeva Vault QMS | Quality Management | 2020 | n/a |
In 2020, AstraZeneca implemented Veeva Vault QMS and Veeva Vault QualityDocs to consolidate quality management capabilities on a single cloud platform. The deployment used Veeva Vault Quality Suite to unify Quality Management and controlled content across the enterprise, positioning Veeva Vault QMS as the central system for quality documentation and process governance.
Veeva Vault QMS and Veeva Vault QualityDocs were configured to centralize quality content and standardize quality processes, providing a single repository for controlled documents and a platform for consistent quality process orchestration. Functional emphasis in the implementation included document control and the orchestration of enterprise quality workflows to support standardized, scalable, and compliant quality operations.
Operational coverage targeted AstraZenecas global quality systems and processes, extending across the enterprise quality organization and supporting worldwide sites through a cloud native architecture. The program focused on unifying quality management and quality content rather than introducing point solutions, enabling consistent governance of global procedures and records within the Quality Management category.
Governance and rollout prioritized a standardized, scalable, efficient, and compliant approach to managing global quality systems, with the stated objective of increasing real-time visibility, efficiency, and speed. Veeva Vault QMS serves as the referenced platform for ongoing quality process control and documentation management as AstraZeneca continues to scale its global quality operations.
|
|
|
Civica Rx | Life Sciences | 150 | $50M | United States | Veeva Systems | Veeva Vault QMS | Quality Management | 2023 | n/a |
In 2023, Civica Rx implemented Veeva Vault QMS as the core component of a consolidated Quality Management deployment supporting its manufacturing and laboratory operations. The deployment is framed as a unified Veeva ecosystem that includes Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training, and the program expanded in 2023 when Civica adopted Veeva Vault LIMS to optimize quality control for a new manufacturing facility.
The implementation of Veeva Vault QMS focused on standardizing quality processes and document control, with Vault QualityDocs providing controlled methods and specifications and Vault Training managing competency and compliance records. Within that environment, Veeva Vault LIMS was configured to allow lab professionals to reference relevant methods and specifications stored in Vault QualityDocs and to surface pertinent quality events from Vault QMS during final QC review.
Operational scope centers on internal manufacturing and testing activities for Civica Rx, with the combined Vault suite supporting lab workflows, final quality control review, and cross-functional visibility across manufacturing and supply chain functions. The integration between Veeva Vault LIMS and Veeva Vault QMS creates a single source of truth for test methods, specifications, and quality events, improving information currency for technicians and quality reviewers.
Governance changes emphasized a unified quality ecosystem and tightened final QC review workflows, aligning laboratory procedures with controlled documents and training records in the Veeva Vault platform. Reported outcomes from the deployment include improved productivity and speed, enhanced transparency across the value chain, and support for right first time production and lead time adherence, all delivered through the consolidated Quality Management architecture.
|
|
|
Quotient Sciences | Life Sciences | 1300 | $300M | United Kingdom | Veeva Systems | Veeva Vault QMS | Quality Management | 2019 | n/a |
In 2019 Quotient Sciences implemented Veeva Vault QMS as its core Quality Management application, launching a Veeva eQMS migration project led from the Quality Assurance function at the Nottingham site. The initiative focused on bringing paper based clinical and quality documents into a controlled electronic repository, establishing Veeva Vault QMS for document control and electronic records management.
Work activities centered on document reformatting and metadata enrichment, with project teams using Microsoft Word and Excel to ensure documents were fit for purpose and system meta tags were applied. The implementation included mapping of documents and master data into migration reports, creating structured migration artefacts to track document state, taxonomy alignment, and readiness for upload to Veeva Vault QMS.
Governance work included staged migration reporting and QA oversight of document templates and metadata standards, supporting operational adoption by Quality Assurance staff in Nottingham. The rollout emphasized procedural mapping and migration traceability, with Project Administrator level ownership of document design, tagging, and master data mapping to sustain the new Quality Management controls.
|
|
|
Recipharm | Life Sciences | 9000 | $1.1B | Sweden | Veeva Systems | Veeva Vault QMS | Quality Management | 2023 | n/a |
In 2023, Recipharm implemented Veeva Vault QMS as part of a unified Veeva Vault Quality deployment to harmonize its global Quality Management environment. The rollout included Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training to standardize quality processes and manage GxP content across Recipharm sites. This implementation is positioned as a single platform to centralize quality oversight, content control, and training administration under the Quality Management category.
Functional implementation centered on document lifecycle and training workflows. Veeva Vault QualityDocs is used to drive GxP content management and information sharing among sites, providing controlled document creation, review and approval flows. Veeva Vault Training is configured to deploy learning content and curricula to operationalize GxP effectiveness and compliance, while Veeva Vault QMS provides a framework for quality process oversight and process orchestration.
Operational coverage spans global site quality teams and regulatory and quality management functions, with the system intended to improve site collaboration and provide a standard approach to quality across the CDMO organization. The narrative emphasizes consolidation of processes and content rather than point integrations, focusing on cross‑site information sharing and consistent training delivery to support manufacturing and regulatory activities.
Governance changes accompanying the deployment target harmonized quality processes and a single set of GxP documentation rules to support inspection readiness and validation activities. Recipharm positioned the platform to enable a standard approach to quality, embedding site collaboration and consistent compliance workflows into day to day quality operations. Outcomes called out by the company include greater quality oversight, more effective use of resources, accelerated validation, and improved inspection readiness, all enabled by the Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training configuration.
|
|
|
Samsung Biologics Co | Life Sciences | 4400 | $1.2B | South Korea | Veeva Systems | Veeva Vault QMS | Quality Management | 2020 | n/a |
In 2020, Samsung Biologics implemented Veeva Vault QMS to unify Quality Management across its global manufacturing, development, and laboratory testing operations. The deployment builds on an existing Veeva footprint, extending Veeva Vault QualityDocs into the Veeva Vault Quality Suite to bring process and content management onto a single cloud platform.
The implementation consolidated document control and quality process workflows, configuring Veeva Vault QMS for standard quality modules such as change control, CAPA, deviation management, and controlled document lifecycle management in line with industry quality management practices. Veeva Vault QMS was configured to centralize quality records, routing and approval flows, and audit trail capabilities to support regulated manufacturing and lab operations.
Architecturally the rollout used Veeva Vault as a cloud native platform to onboard internal teams and external stakeholders, incorporating pharmaceutical and biotech customers, contract manufacturers, and suppliers into a unified quality process. Integration with Vault QualityDocs provided end to end linkages between quality content and quality workflows, enabling visibility across product lifecycle stages from development through commercial manufacturing.
Governance changes focused on harmonizing global quality processes and establishing common workflow orchestration, with standardized routing, electronic approvals, and centralized oversight to improve transparency and compliance across sites. The program delivered greater visibility and compliance across global manufacturing as stated by Samsung Biologics, positioning Samsung Biologics Veeva Vault QMS Quality Management to support quality, compliance, and document control functions across its enterprise.
|
|
|
|
Consumer Packaged Goods | 3000 | $300M | Mexico | Veeva Systems | Veeva Vault QMS | Quality Management | 2020 | n/a |
|
|
|
|
Life Sciences | 650 | $250M | United States | Veeva Systems | Veeva Vault QMS | Quality Management | 2018 | n/a |
|
Buyer Intent: Companies Evaluating Veeva Vault QMS
- Barron & Barron Photography, a United States based Media organization with 10 Employees
- Profil Mainz & Co., a Germany based Life Sciences company with 110 Employees
- Marsh, a United States based Insurance organization with 90000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated |
|---|---|---|---|---|---|---|
| Barron & Barron Photography | Media | 10 | $1M | United States | 2025-11-03 | |
| Profil Mainz & Co. | Life Sciences | 110 | $19M | Germany | 2025-10-08 | |
| Marsh | Insurance | 90000 | $24.5B | United States | 2025-09-30 | |
| Banking and Financial Services | 4 | $1M | United States | 2025-07-09 | ||
| Life Sciences | 17 | $4M | United States | 2025-06-26 |